Description
Identification of therapeutically relevant gene mutations for Cancer
ONCQUER CTC MONITORING (2 TEST)
Identification of therapeutically relevant gene mutations for Cancer
TAT:
Specimen Type:
Genomics Single Test
Other Tests
-
264%
OncQuer TM Germline Mutation Panel by NGS
Identification of gene mutations that increase risk of cancer or has therapeutic implications in an affected individual
OncQuer TM Germline Mutation Panel by NGS
Identification of gene mutations that increase risk of cancer or has therapeutic implications in an affected individual
-
264%
OncQuer TM Scout LB 56 Gene Test
Identification of therapeutically relevant gene mutations for Myeloid cancerCancer
OncQuer TM Scout LB 56 Gene Test
Identification of therapeutically relevant gene mutations for Myeloid cancerCancer
-
264%
OncQuer TM 500 gene panel (Basic)
Identification of therapeutically relevant gene mutations for Cancer
OncQuer TM 500 gene panel (Basic)
Identification of therapeutically relevant gene mutations for Cancer
-
260%
IGVH Somatic Hyper Mutation Assay
Colon and Lung Cancer marker
Reviews
There are no reviews yet.